Application of iPSC induced pluripotent stem cell gene therapy in CGT

Solution for iPSC induced pluripotent stem cell research（Application of iPSC induced pluripotent stem cell gene therapy in CGTplan）

Induced pluripotent stem cells (iPSCs) are obtained by "reprogramming" adult cells into a stem cell state. This reprogramming process typically involves introducing several key genes (such as OCT4, SOX2, KLF4, and c-MYC, commonly referred to as "Yamanaka factors") into somatic cells, thereby restoring these cells to a pluripotent state similar to embryonic stem cells.

The development of iPSC technology can be attributed to Japanese scientist Shinya Yamanaka, who successfully transformed adult cells into a pluripotent state in 2006. IPSCs have similar characteristics to embryonic stem cells and can differentiate into various cell types, including neurons, cardiomyocytes, liver cells, etc.

For more content, please visit the Manbo Biotechnology website:Application of iPSC induced pluripotent stem cell gene therapy in CGTplanplan

IPSC based cell therapy and its application areas:

Cell therapy based on iPSCs is a revolutionary advancement in regenerative medicine, which utilizes somatic cells collected from patients to be reprogrammed and transformed into stem cells with multiple differentiation potentials, which then differentiate into specific types of cells for treatment. This method has high potential for application and can provide personalized treatment for various diseases.

Neurodegenerative diseases: iPSCs can be used to generate nerve cells, providing new hope for the treatment of diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), ALS, etc.

Cardiovascular disease: Using iPSC technology to generate heart cells for repairing heart tissue or treating cardiovascular diseases such as myocardial infarction.

• Treatment of diabetes: iPSCs can differentiate into islet beta cells, which may be a potential therapeutic method for type 1 or even some type 2 diabetes patients.

Regenerated damaged tissue: The ability of iPSCs can be used to produce various types of cells for the treatment of tissue damage caused by diseases or injuries.

From R&D to process development to clinical production GMP level solutions: